The Company is actively conducting research on formulations utilizing its proprietary High Throughput Experimentation (HTE) technology platforms and its molecular skin penetration enhancer systems (MPE™s) to build its topical and transdermal drug delivery (TTDD) pipeline of pain products. The Company has undertaken extensive formulation discovery efforts resulting in a pipeline of topical products consisting of several early stage pain products and wound healing.